<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02752269</url>
  </required_header>
  <id_info>
    <org_study_id>26-446 ex 13/14</org_study_id>
    <nct_id>NCT02752269</nct_id>
  </id_info>
  <brief_title>Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome</brief_title>
  <official_title>Early Detection of Pulmonary- and Pulmonary Vascular Disease in Patients Suffering From Sjögren Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to the literature available pulmonary hypertension is present in 12 to 23% of&#xD;
      patients suffering from Sjögren Syndrome. However epidemiological data are based on&#xD;
      non-invasive measurements using echocardiography. Furthermore, no data are available&#xD;
      regarding exercise hemodynamics in those patients.&#xD;
&#xD;
      This study investigates pulmonary hemodynamics at rest and during exercise in patients&#xD;
      suffering from primary and secondary Sjögren Syndrome. Patients under suspicion for pulmonary&#xD;
      hypertension (PH) will be offered further investigations including right heart&#xD;
      catheterization.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with primary and secondary Sjögren Syndrome will be investigated using&#xD;
      echocardiography, exercise echocardiography, pulmonary function testing, laboratory testing,&#xD;
      electrocardiogram and 6 minute walking test. Those patients under clinical suspicion for&#xD;
      pulmonary hypertension will be offered further investigations including right heart&#xD;
      catheterization to rule out or verify the diagnosis of manifest pulmonary hypertension.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of pulmonary hypertension in Sjögren syndrome</measure>
    <time_frame>2 hours</time_frame>
    <description>% of patients with mean pulmonary arterial pressure &gt; 25 mmHg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>forced vital capacity</measure>
    <time_frame>2 hours</time_frame>
    <description>% predicted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>systolic pulmonary arterial pressure at 50 Watts</measure>
    <time_frame>2 hours</time_frame>
    <description>mmHg</description>
  </secondary_outcome>
  <enrollment type="Actual">86</enrollment>
  <condition>Sjögren Syndrome</condition>
  <condition>Pulmonary Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with primary or secondary Sjögren Syndrome.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  informed Consent&#xD;
&#xD;
          -  diagnosis of Sjögren Syndrome&#xD;
&#xD;
          -  age: 18 - 90 yrs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  uncontrolled systemic hypertension (at rest &gt;150 mmHg systolic or 95 mmHg diastolic)&#xD;
&#xD;
          -  relevant systolic (EF&lt;50%) or diastolic (&gt;Grade 1) left ventricular dysfunction&#xD;
&#xD;
          -  uncontrolled ventricular arrhythmias&#xD;
&#xD;
          -  uncontrolled supraventricular bradycardia or tachycardia&#xD;
&#xD;
          -  myocardial infarction within the last 12 months&#xD;
&#xD;
          -  pulmonary embolism within the last 6 months&#xD;
&#xD;
          -  larger surgical interventions within the last 12 months&#xD;
&#xD;
          -  musculoskeletal or vascular disease, that may affect ergometric investigations&#xD;
&#xD;
          -  pregnancy (anamnesis)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horst Olschewski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MUG</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>November 24, 2015</study_first_submitted>
  <study_first_submitted_qc>April 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2016</study_first_posted>
  <last_update_submitted>March 17, 2020</last_update_submitted>
  <last_update_submitted_qc>March 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

